
==== Front
World J Pediatr Surg
World J Pediatr Surg
wjps
wjps
World Journal of Pediatric Surgery
2096-6938
2516-5410
BMJ Publishing Group BMA House, Tavistock Square, London, WC1H 9JR

10.1136/wjps-2024-000864
wjps-2024-000864
Perspective
1506
Hirschsprung disease: common and uncommon variants
https://twitter.com/LilySCheng
http://orcid.org/0000-0001-5125-7197
Cheng Lily S 1ptr6ey@uvahealth.org

Wood Richard J 2richard.wood@nationwidechildrens.org

1 Department of Surgery, Division of Pediatric Surgery, University of Virginia, Charlottesville, Virginia, USA
2 Department of Pediatric Colorectal and Pelvic Reconstructive Surgery, Nationwide Children's Hospital, Columbus, Ohio, USA
Dr; ptr6ey@uvahealth.org
None declared.

2024
28 8 2024
7 3 e00086431 5 2024
12 8 2024
Copyright © Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
2024
https://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.

Colorectal Surgery
Child Health
Gastroenterology
http://dx.doi.org/10.13039/100000062 National Institute of Diabetes and Digestive and Kidney Diseases K08DK133673
==== Body
pmcOverview of short-segment Hirschsprung disease

The most common variant of Hirschsprung disease (HSCR) is short-segment or rectosigmoid disease. The majority (70%–85%) of HSCR is limited to the rectum or sigmoid colon.1 These patients usually present in the neonatal period with ‘typical’ signs and symptoms: failure to pass meconium within the first 24–48 hours, abdominal distention, vomiting, explosive passage of stool/gas, and failure to thrive.1 2 Patients may also present with signs and symptoms of Hirschsprung-associated enterocolitis (HAEC), which include abdominal tenderness, fever, explosive diarrhea, and bloody stools.3 Rectal irrigation is usually an effective first-line management strategy in patients with short-segment HSCR and is the mainstay of treatment for HAEC.

In short-segment HSCR, a contrast enema may show a transition zone between contracted distal aganglionic rectosigmoid and dilated proximal ganglionic colon. It is worth noting, however, that the radiographic transition zone may not correlate with the histologic transition zone.4 A rectosigmoid ratio of <1 is also suggestive of HSCR.5 Though imaging may be helpful in establishing the diagnosis and formulating a surgical plan, rectal biopsy remains the gold standard for diagnosing all variants of HSCR.6

Most short-segment HSCR can be treated with a primary endorectal pull-through without the need for diversion. Timing of the pull-through and the type of pull-through performed depends on surgeon preference and comfort level. A recent retrospective study found that delaying primary pull-through ≥31 days with interim rectal irrigations is a safe alternative to neonatal repair; most of the studied patients had short-segment disease.7 This delayed approach may make technical aspects of the operation easier and has the added benefit of allowing parents to gain experience with rectal irrigation. Studies comparing Swenson, Yancey-Soave and Duhamel pull-through for short-segment disease have been limited by small sample sizes, heterogeneous patient selection and their retrospective nature. Many of these studies have reported conflicting results. One study looking mostly at patients with short-segment HSCR found that patients had less soiling after a Yancey-Soave pull-through compared with Duhamel.8 A survey of European Paediatric Surgeons’ Association (EUPSA) members found that most surgeons (65%) would perform a Yancey-Soave pull-through for short-segment HSCR.9 A total transanal approach is possible for short-segment HSCR and has gained popularity due to its minimally invasive and scarless nature,9 but it is not yet known how long-term outcomes compare to laparoscopic pull-through.1012 Caution with the total transanal approach is advised since, even for short-segment disease, the transition zone may be greater than 5 cm and additional mobilization may be needed.13 Identifying the level of normally ganglionated bowel prior to starting the transanal dissection prevents the situation of unexpectantly discovering long-segment disease after having already performed the rectal dissection. This can be achieved either with laparoscopy or transumbilical biopsy with a rectal dilator. Regardless of the type of pull-through performed, the presence of normal ganglion cells at the circumferential proximal resection margin should be confirmed by frozen section at the time of pull-through.14

Long-term outcomes for short-segment HSCR are generally favorable, but complications are not uncommon and postoperative vigilance is paramount. One US-based study found that 17% of patients were re-admitted to the hospital within 30 days of pull-through procedure, including 9% with HAEC. Within 2 years of pull-through, 10% of patients required a reoperation.15 Several guidelines exist for the evaluation and management of the patient with HSCR who is not doing well after pull-through surgery.1621 Guidelines also exist for the early diagnosis and treatment of HAEC, a major cause of disease-related mortality in patients with HSCR.3 So far studies have found no benefit to the use of prophylactic Botox22 23 or probiotics24 for the prevention of HAEC. Rectal irrigation, often in combination with antibiotics, is currently the only effective remedy for HAEC.3

Long-segment and total colonic HSCR

Though the definition of long-segment HSCR varies in the literature, the American Pediatric Surgical Association Outcomes and Evidence Based Practice Committee defines long-segment disease as aganglionosis from sigmoid colon-descending colon junction up to the cecum with ganglion cells present in the colon, or in other words, aganglionosis that extends above the sigmoid colon but does not involve the entire colon.25 This is in contrast to total colonic HSCR, which is defined as aganglionosis of the entire colon and less than 5 cm of distal small intestine and small intestinal HSCR which is defined as aganglionosis involving greater than 5 cm of small intestine25 (table 1).

Table 1 Recommend nomenclature for common and uncommon variants of Hirschsprung disease

Nomenclature	Definition	
Ultrashort-segment	No clear definition and usage of this term should be abandoned	
Short-segment	Aganglionosis up to the sigmoid colon-descending colon junction	
Long-segment	Aganglionosis that extends above the sigmoid colon but does not involve the entire colon	
Total colonic	Aganglionosis of the entire colon and <5 cm of terminal ileum	
Small intestinal	Aganglionosis involving >5 cm of small intestine	
Total intestinal	<20 cm of ganglionated intestine beyond the ligament of Treitz	
Skip segment	Segmental aganglionosis (skip lesions) in one or more areas of the intestine	
Adapted from Kawaguchi AL, Guner YS, Somme S,et al. Management and outcomes for long-segment Hirschsprung disease: A systematic review from the APSA Outcomes and Evidence Based Practice Committee. 2021;56(9):. doi: /j.jpedsurg.2021.03.04625

About 15% of HSCR is long-segment.25 In contrast to short-segment HSCR, contrast enema is less accurate in predicting the transition zone for long-segment and total colonic aganglionosis and the rectosigmoid ratio may be normal in these variants.4 Instead, a microcolon or a comma-shaped colon may be seen.25 Optimum timing of pull-through surgery for long-segment HSCR is complex and depends on several factors. In many cases, intestinal diversion is needed as rectal irrigations may not be effective for decompressing long-segment HSCR. Most surgeons recommend a temporary ileostomy and full-thickness colonic mapping if ganglion cells cannot be identified proximal to the splenic flexure.26 In operations for long-segment HSCR, blood supply to the pull-through segment is an important consideration. Disease extending to the descending colon requires mobilization of the splenic flexure and may require ligation of the left colic artery. Disease extending to the transverse colon or ascending colon may require ligation of the middle colic artery or right colic artery, respectively. Furthermore, de-rotation of the colon is required to prevent obstruction of the distal duodenum and twisting of the mesentery around the ileocolic artery. In all of these scenarios, special care must be taken to preserve the marginal artery which will supply the pull-through segment.

Approximately 8% of HSCR is total colonic.25 Unlike short-segment HSCR which has a 4:1 male predominance, total colonic HSCR is equally common in girls and is more likely to be associated with a family history of HSCR.2 Patients with total colonic HSCR should be managed with a diverting ileostomy at the time of diagnosis with close follow-up for nutritional support and monitoring of fluid/electrolyte balances. A pull-through operation can be performed when the ileostomy output reaches an applesauce-like consistency and is <30 mL/kg/day.26 Fiber supplements and loperamide can be used to help achieve these goals. In addition, urine sodium should be >20 mmol/L and the patient should be maintaining an adequate growth trajectory. These milestones are usually met between 9 months and 18 months of age.26 As with short-segment HSCR, there are few studies that rigorously compare the various surgical approaches to total colonic HSCR. In a survey of EUPSA members, Duhamel pull-through was the most common technique for total colonic HSCR (52%).9 A recent multicenter study comparing Swenson versus Duhamel pull-through for total colonic aganglionosis found equivalent short-term and medium-term outcomes.27 Long-term outcomes after pull-through for total colonic HSCR are expectedly worse than those for short-segment HSCR with 17.5% of patients requiring some sort of reoperation and 6.5% of patients requiring conversion to a permanent ileostomy due to postoperative complications.28

An extremely rare variant of HSCR is skip segment (skip lesion) or segmental aganglionosis in which a normally ganglionated segment of intestine is surrounded proximally and distally by aganglionic intestine.29 This is most commonly associated with total colonic HSCR.30 With preoperative colonic mapping, skip segment HSCR may be recognized and segments of functional colon may be preserved during pull-through surgery.

Management of total intestinal aganglionosis

Near-total or total intestinal aganglionosis is rare (<1% of all cases)1 and is defined as ganglionated small bowel length of <20 cm past the ligament of Treitz.25 This rare variant can be incredibly challenging to manage and the risk of intestinal failure is high. A recent consensus statement from the European Reference Network for rare Inherited and Congenital Anomalies recommended early referral to an intestinal rehabilitation center with timely listing for small bowel transplantation. They found that children with less than 80 cm of small bowel remaining had a poorer chance of weaning off parenteral nutrition.31

Once total intestinal aganglionosis is confirmed pathologically, a jejunostomy should be formed at least 40 cm distal to the ligament of Treitz. This will inevitably include aganglionic intestine proximal to the stoma. There is no benefit to resecting proximal aganglionic intestine beyond 40 cm.31 It is the authors’ opinion that the distal diverted bowel should be resected as this may increase the risk of enterocolitis and bacterial overgrowth; however, some surgeons may leave most or all of the aganglionic intestine in situ at the time of proximal diversion and consider resection only if symptoms of HAEC or overgrowth develop. Preserving the aganglionic intestine has the advantage of preserving the intra-abdominal domain for future intestinal transplantation and leaves the option for future colon patch-type pull-through procedures.

Treatment options for total intestinal HSCR are similar to treatments for other forms of intestinal failure due to short gut, namely: parenteral nutrition, GLP-2 agonists, bowel lengthening procedures, and intestinal transplantation. Specific to HSCR, there are several autologous intestinal reconstructive techniques intended to functionalize aganglionic bowel.32 33 These operations are rarely performed now in the era of intestinal transplantation. A recent meta-analysis reported a survival rate of 66% after intestinal transplantation for total intestinal aganglionosis.34

Delayed diagnosis and strategies for megarectum

Some patients with HSCR present later in life with long-standing symptoms of constipation. There is no clear age delineation for delayed diagnosis, but studies suggest that worse outcomes may exist for patients diagnosed at 1 year of age and older.35 36 Patients with delayed diagnosis usually have short-segment HSCR.37 These patients may have a very distended rectum and/or colon (megarectum/megacolon) due to chronic functional obstruction. Motility in the dilated segments of colon is often impaired as it is in chronic idiopathic constipation.38 Preoperative decompression of dilated colorectum should be considered either with rectal irrigations or a diverting stoma. Irrigations can prove challenging in this situation as the patients are older at initiation and the stool is often very thick. The goal of such decompression is both to improve function in the ganglionic bowel as well as to reduce colonic dilation and facilitate safe coloanal anastomosis. Manometry may be helpful in determining the function of chronically dilated segments and may guide operative planning for resection and pull-through.39 In one study of 90 patients diagnosed with HSCR as adults, long-term functional outcome was strongly correlated with the degree of preoperative megacolon present.40

A recent multi-institutional study from the Pediatric Colorectal and Pelvic Learning Consortium found that patients diagnosed with HSCR at later ages were more likely to require intervention for constipation or incontinence and to require a diverting ostomy after pull-through.36 Other studies have similarly found that patients with late diagnosis of HSCR are more likely to have postoperative complications such as anastomotic dehiscence.35 37 Thus, a protective temporary diverting ostomy may be considered prior to or at the time of pull-through for patients with delayed diagnosis of HSCR.

Data availability statement

No data are available.

Funding: This study was funded by the National Institute of Diabetes and Digestive and Kidney Diseases (Grant number: K08DK133673).

Patient consent for publication: Not applicable.

Ethics approval: Not applicable.

Provenance and peer review: Not commissioned; externally peer reviewed.
==== Refs
References

1 Langer JC Hirschsprung disease Curr Opin Pediatr 2013 25 368 74 10.1097/MOP.0b013e328360c2a0 23615177
2 Montalva L Cheng LS Kapur R et al Hirschsprung disease Nat Rev Dis Primers 2023 9 54 10.1038/s41572-023-00465-y 37828049
3 Gosain A Frykman PK Cowles RA et al Guidelines for the diagnosis and management of Hirschsprung-associated enterocolitis Pediatr Surg Int 2017 33 517 21 10.1007/s00383-017-4065-8 28154902
4 Proctor ML Traubici J Langer JC et al Correlation between radiographic transition zone and level of aganglionosis in Hirschsprung’s disease: Implications for surgical approach J Pediatr Surg 2003 38 775 8 10.1016/jpsu.2003.50165 12720192
5 Diamond IR Casadiego G Traubici J et al The contrast enema for Hirschsprung disease: predictors of a false-positive result J Pediatr Surg 2007 42 792 5 10.1016/j.jpedsurg.2006.12.031 17502185
6 Ambartsumyan L Smith C Kapur RP Diagnosis of Hirschsprung Disease Pediatr Dev Pathol 2020 23 8 22 10.1177/1093526619892351 31791203
7 Kastenberg ZJ Taylor MA Durham MM et al Perioperative and long-term functional outcomes of neonatal versus delayed primary endorectal pull-through for children with Hirschsprung disease: A pediatric colorectal and pelvic learning consortium study J Pediatr Surg 2021 56 1465 9 10.1016/j.jpedsurg.2021.04.024 34052005
8 Gunadi M Stevie T et al Long-term functional outcomes of patients with Hirschsprung disease following pull-through BMC Pediatr 2022 22 246 10.1186/s12887-022-03301-6 35505310
9 Zani A Eaton S Morini F et al European Paediatric Surgeons’ Association Survey on the Management of Hirschsprung Disease Eur J Pediatr Surg 2017 27 96 101 10.1055/s-0036-1593991 27898990
10 Langer JC Laparoscopic and transanal pull-through for Hirschsprung disease Semin Pediatr Surg 2012 21 283 90 10.1053/j.sempedsurg.2012.07.002 22985833
11 Singh R Cameron BH Walton JM et al Postoperative Hirschsprung’s enterocolitis after minimally invasive Swenson’s procedure J Pediatr Surg 2007 42 885 9 10.1016/j.jpedsurg.2006.12.055 17502205
12 Celtik U Yavuz I Ergün O Transanal endorectal or transabdominal pull-through for Hirschsprung’s disease; which is better? A systematic review and meta-analysis Pediatr Surg Int 2023 39 89 10.1007/s00383-023-05378-1 36692536
13 Kapur RP Kennedy AJ Histopathologic delineation of the transition zone in short-segment Hirschsprung disease Pediatr Dev Pathol 2013 16 252 66 10.2350/12-12-1282-OA.1 23495711
14 Hwang S Kapur RP Advances and Pitfalls in the Diagnosis of Hirschsprung Disease Surg Pathol Clin 2020 13 567 79 10.1016/j.path.2020.07.001 33183721
15 Apfeld JC Wood RJ Halleran DR et al Relationships Between Hospital and Surgeon Operative Volumes and Surgical Outcomes in Hirschsprung’s Disease J Surg Res 2021 257 379 88 10.1016/j.jss.2020.08.014 32892134
16 Ahmad H Levitt MA Yacob D et al Evaluation and Management of Persistent Problems After Surgery for Hirschsprung Disease in a Child Curr Gastroenterol Rep 2021 23 18 10.1007/s11894-021-00819-0 34633517
17 Ahmad H Yacob D Halleran DR et al Evaluation and treatment of the post pull-through Hirschsprung patient who is not doing well; Update for 2022 Semin Pediatr Surg 2022 31 151164 10.1016/j.sempedsurg.2022.151164 35690463
18 Ambartsumyan L Patel D Kapavarapu P et al Evaluation and Management of Postsurgical Patient With Hirschsprung Disease Neurogastroenterology & Motility Committee: Position Paper of North American Society of Pediatric Gastroenterology, Hepatology, and Nutrition (NASPGHAN) J Pediatr Gastroenterol Nutr 2023 76 533 46 10.1097/MPG.0000000000003717 36720091
19 Langer JC Rollins MD Levitt M et al Guidelines for the management of postoperative obstructive symptoms in children with Hirschsprung disease Pediatr Surg Int 2017 33 523 6 10.1007/s00383-017-4066-7 28180937
20 Saadai P Trappey AF Goldstein AM et al Guidelines for the management of postoperative soiling in children with Hirschsprung disease Pediatr Surg Int 2019 35 829 34 10.1007/s00383-019-04497-y 31201486
21 Levitt MA Dickie B Peña A Evaluation and treatment of the patient with Hirschsprung disease who is not doing well after a pull-through procedure Semin Pediatr Surg 2010 19 146 53 10.1053/j.sempedsurg.2009.11.013 20307851
22 Ahmad H Rentea RM Knaus ME et al Routine botulinum toxin injection one month after a Swenson pull-through does not change the incidence of Hirschsprung associated enterocolitis J Pediatr Surg 2022 57 1453 7 10.1016/j.jpedsurg.2021.11.029 34991869
23 Encisco EM Lim IIP Velazco CS et al Hirschsprung-Associated Enterocolitis at a Referral Institution: ARetrospective Review J Pediatr Surg 2023 58 1578 81 10.1016/j.jpedsurg.2023.04.008 37221126
24 Mei F Wu M Zhao L et al Probiotics for the prevention of Hirschsprung-associated enterocolitis Cochrane Database Syst Rev 2022 4 CD013714 10.1002/14651858.CD013714.pub2 35470864
25 Kawaguchi AL Guner YS Sømme S et al Management and outcomes for long-segment Hirschsprung disease: A systematic review from the APSA Outcomes and Evidence Based Practice Committee J Pediatr Surg 2021 56 1513 23 10.1016/j.jpedsurg.2021.03.046 33993978
26 Wood RJ Garrison AP Total Colonic Aganglionosis in Hirschsprung disease Semin Pediatr Surg 2022 31 151165 10.1016/j.sempedsurg.2022.151165 35690465
27 Halaweish I Srinivas S Farooqui Z et al Duhamel Versus Swenson Pull-Through for Total Colonic Aganglionosis: A Multi-Institutional Study J Pediatr Surg 2024 59 216 9 10.1016/j.jpedsurg.2023.10.017 37973423
28 Laughlin DM Friedmacher F Puri P Total colonic aganglionosis: a systematic review and meta-analysis of long-term clinical outcome Pediatr Surg Int 2012 28 773 9 10.1007/s00383-012-3117-3 22842648
29 Ahmad H Vilanova-Sánchez A Amengual I et al Skip Segment Hirschsprung Disease Managed by Pull-Through of the Right Colon European J Pediatr Surg Rep 2021 9 e28 32 10.1055/s-0041-1726347
30 O’Donnell A-M Puri P Skip segment Hirschsprung’s disease: a systematic review Pediatr Surg Int 2010 26 1065 9 10.1007/s00383-010-2692-4 20714729
31 Granström AL Irvine W Hoel AT et al Ernica Clinical Consensus Statements on Total Colonic and Intestinal Aganglionosis J Pediatr Surg 2024 00295 1 10.1016/j.jpedsurg.2024.04.019
32 Fusaro F Morini F Mutanen A et al Autologous Intestinal Reconstructive Surgery in the Management of Total Intestinal Aganglionosis J Pediatr Gastroenterol Nutr 2019 68 635 41 10.1097/MPG.0000000000002260 30614951
33 Pini Prato A Faticato MG Falconi I et al Skipped aganglionic lengthening transposition (SALT) for short bowel syndrome in patients with total intestinal aganglionosis: technical report and feasibility Pediatr Surg Int 2020 36 1507 10 10.1007/s00383-020-04763-4 33095274
34 Nakamura H Henderson D Puri P A meta-analysis of clinical outcome of intestinal transplantation in patients with total intestinal aganglionosis Pediatr Surg Int 2017 33 837 41 10.1007/s00383-017-4107-2 28600659
35 Tan Y-W Chacon CS Geoghegan N et al Late Diagnosis of Hirschsprung’s Disease: Definition and Implication on Core Outcomes Eur J Pediatr Surg 2022 32 512 20 10.1055/s-0042-1744147 35263774
36 Ullrich S Austin K Avansino JR et al Does Delayed Diagnosis of Hirschsprung Disease Impact Post-operative and Functional Outcomes? A Multi-Center Review From the Pediatric Colorectal and Pelvic Learning Consortium J Pediatr Surg 2024 59 1250 5 10.1016/j.jpedsurg.2024.03.034 38677965
37 Stensrud KJ Emblem R Bjørnland K Late diagnosis of Hirschsprung disease--patient characteristics and results J Pediatr Surg 2012 47 1874 9 10.1016/j.jpedsurg.2012.04.022 23084200
38 Cheng LS Goldstein AM Surgical Management of Idiopathic Constipation in Pediatric Patients Clin Colon Rectal Surg 2018 31 89 98 10.1055/s-0037-1609023 29487491
39 Fu Y Gayer C Gould M et al Utility of colonic manometry in children with Hirschsprung disease J Pediatr Gastroenterol Nutr 2024 78 1217 24 10.1002/jpn3.12227 38682419
40 Vorobyov GI Achkasov SI Biryukov OM Clinical features’ diagnostics and treatment of Hirschsprung’s disease in adults Colorectal Dis 2010 12 1242 8 10.1111/j.1463-1318.2009.02031.x 19674017
